Research Solutions Posts Flat Q1 Profit as Transaction Revenue Slides 8%
RSSS is trading near its 52-week low of $1.77 (6.8% above the low).
Summary
Research Solutions reported fiscal Q1 2027 revenue of $11.9 million, down 3.3% from $12.3 million a year ago, as transaction revenue fell 8.2% to $6.6 million while platform revenue grew 3.7% to $5.3 million. Net income was essentially flat at $765,000, or $0.02 per diluted share, versus $749,000 a year earlier, and adjusted EPS beat. Total ARR rose 5.7% to $22.5 million, with B2B ARR up 11.5% to $16.5 million, but B2C ARR declined 7.5% to $6.0 million. Gross margin improved 300 basis points to 53.6% on the platform mix shift, yet adjusted EBITDA fell 30.3% to $1.0 million as G&A jumped 32.8% on legal and severance costs. The company ended the quarter with $12.6 million in cash after paying $1.2 million of the Scite earn-out. This follows the November 11 announcement of a $1 million enterprise Scite agreement with a Fortune 500 biopharma company, the largest such deal to date. Management hosts its earnings call November 17 at 9:00 a.m. ET.
At the time of this announcement, RSSS was trading at $1.89 on NASDAQ in the Technology sector, with a market capitalization of approximately $63.8M. The 52-week trading range was $1.77 to $3.38. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.